# Denove Inc.
## Project Reno - investment banking
## Denove is considering being acquired (in anticipation of obtaining FDA approval to commercialize the drug in the near future)
## Aug 15, 2020
## Authors RIHAD, SAMIRA, SALENA

<img src="./gallery/rockwall.png"/>

Welcome! We’re so excited to have you here with us!

***Rockwall Analytics is naturally curious and we challenge the status quo***

This multi-part task series worked on by our strategy advisors, **RIHAD,  SAMIRA, SALENA** showcase a deep understanding on what Rockwall Analytics does and help set you up for success when you decide to engage with us

## Background

>Denove, a biopharmaceutical company. It has developed an innovative drug to combat renal cell cancer. The drug is in Phase III trials with the Food and Drugs Administration (FDA). The results of the Phase II and Phase III trials to date is promising – 28% of patients treated with the drug show a minimum 38% shrinkage of targeted lesions  

>Denove is considering being acquired (in anticipation of obtaining FDA approval to commercialize the drug in the near future)

## Objective

>Review an NDA and prepare our client's negotiating position on key drafting changes

Rockwall Analytics partners with leaders in business and society to tackle their most important challenges and capture their greatest opportunities. Our diverse, team bring deep industry and functional expertise and a range of perspectives to spark impactful change through leading-edge management consulting as well as data science, technology and design, and business purpose. We work in a uniquely collaborative model across the firm and throughout all levels of the client organization to deliver results that help our clients thrive

In this experience, we share insight into what it’s like to solve meaningful challenges with our diverse and forward-thinking team and how top-tier consultants have tackled this multi-part task series

At **Rockwall Analytics** we believe in the power of the elemental. In atoms we discovered the building blocks of all matter, exploding our understanding of the world around us as we peered through microscopes or looked up to the stars. In DNA we unearthed the being blocks of all life, determining the code of our makeup and our links to the world around us. In data points, we capture the behavioural blocks of humanity – ***and it’s only now that we are beginning to fully embrace their potential***. These three breakthroughs of the modern age all deliver one simple lesson: we can neither make sense of the whole without knowledge of the parts, nor harness the elemental units without the power to combine them to create a bigger picture

That’s where we come in. Through data science and Artificial Intelligence, we make meaning from data like never before. Our solutions make sense of what has happened and what will, could or should be done to re-shape industries and societies around the needs of the people they serve. So, we believe in using data for progress, with great care and responsibility. We believe in better goods, better services, better experiences, and for the benefits of the data age to be fairly shared for a brighter future

**We believe in data powering possibilities**

# Ethics Declarations
## Competing Interests
The authors declare no competing interests

# Rights & Permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

![](https://drive.google.com/uc?export=view&id=1i7fzIUxz-oEs8V4uMdoZCQUl51NMrbVz)
